• All Courts
  • Federal Courts
  • Bankruptcies
  • PTAB
  • ITC
Track Search
Export
Download All
4 results

Neurelis, Inc. v. Aquestive Therapeutics, Inc.

Docket 21-1038, U.S. Court of Appeals, Federal Circuit (Oct. 9, 2020)
05/19/2021
05/19/2021 38 Notice from Appellee Aquestive Therapeutics, Inc. regarding conflicts with oral argument. None. Service: 05/19/2021 by email. [775977] [21-1038] [Mi...
cite Cite Docket

No. 50

Document Neurelis, Inc. v. Aquestive Therapeutics, Inc., 21-1038, No. 50 (Fed. Cir. Oct. 7, 2021)

cite Cite Document

No. 50 Judgment

Document Neurelis, Inc. v. Aquestive Therapeutics, Inc., 21-1038, No. 50 (Fed. Cir. Oct. 7, 2021)
Motion for Judgment
United States Court of Appeals for the Federal Circuit
WENDY L. DEVINE, Wilson Sonsini Goodrich & Rosati, San Francisco, CA, argued for appellant.
Also represented by RICHARD TORCZON, Washington, DC; LORELEI WESTIN, San Diego, CA; JEFFREY WILLIAM GUISE, Eversheds Suth- erland (US) LLP, San Diego, CA.
DANIEL A. SCOLA, JR., Hoffmann & Baron, LLP, Parsip- pany, NJ, argued for appellee.
Also represented by MICHAEL I. CHAKANSKY; JOHN T. GALLAGHER, Syosset, NY.
cite Cite Document

No. 42

Document Neurelis, Inc. v. Aquestive Therapeutics, Inc., 21-1038, No. 42 (Fed. Cir. Aug. 20, 2021)

cite Cite Document